智雲健康(09955.HK):安徽智醫慧雲科技獲增資2億元
格隆匯1月12日丨智雲健康(09955.HK)發佈公吿,2024年1月12日,公司、目標公司、智雲匯醫(公司的間接全資子公司)、杭州康晟(目標公司的直接全資子公司)、蕪湖康健及投資者(即產業基金、鏡湖振業及蕪湖京新)訂立增資協議,據此,(其中包括)投資者同意以現金出資方式向目標公司出資合共人民幣2億元,以換取目標公司經擴大註冊資本合共約4.26%股權。
就增資而言,公司、目標公司、智雲匯醫、杭州康晟、蕪湖康健及投資者於2024年1月12日訂立股東協議(將於完成日期生效),以規管(其中包括)目標公司集團的事務、業務及管理,以及目標公司股東之間的關係、權利及責任。
目標公司(即安徽智醫慧雲科技有限公司,公司的間接非全資子公司)為一家於2023年5月12日在中國成立的有限公司。其主要從事提供醫療用品和SaaS服務、為製藥公司提供數字營銷服務、產品銷售及營銷以及其他慢病管理相關業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.